Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lopez

Showing results (291-300 of 308) with videos related to

Pageof 31
Sort By:
Neuron|March 11, 2017
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic OpportunitiesFiona M Menzies, Angeleen Fleming, Andrea Caricasole, et al.
Southern Medical Journal|June 1, 2023
STI Testing among Medicaid Enrollees Initiating PrEP for HIV Prevention in Six Southern StatesPaul Lanier, Susan Kennedy, Angela Snyder, et al.
Vaccines|February 26, 2025
Immunosuppressive Therapy Modifies Anti-Spike IgG Subclasses Distribution After Four Doses of mRNA Vaccination in a Cohort of Kidney Transplant RecipientsIgnacio Juarez, Isabel Pérez-Flores, Arianne S Aiffil Meneses, et al.
Physiological Reports|January 19, 2021
17β-estradiol reduces SARS-CoV-2 infection in vitroRobertha Mariana Rodrigues Lemes, Angelica Jardim Costa, Cynthia Silva Bartolomeo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2025
Palbociclib, trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer: randomised phase II, SOLTI-1303 PATRICIA trialEva Ciruelos, Tomás Pascual, Guillermo Villacampa, et al.
The Journal of Antimicrobial Chemotherapy|September 19, 2023
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimensDaniel Podzamczer, Arkaitz Imaz, Ana Lopez-Lirola, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 28, 2018
Prospective assessment of diagnostic tests for pediatric penicillin allergy: From clinical history to challenge testsMaría Dolores Ibáñez, Pablo Rodríguez Del Río, Eva Maria Lasa, et al.
Plos One|September 8, 2018
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trialsLucia Lopez-Anglada, Cecilia Cueto-Felgueroso, Laura Rosiñol, et al.
Cancers|July 13, 2024
Breast Cancer Patient's Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II-III DiseaseCatalina Falo, Juan Azcarate, Sergi Fernandez-Gonzalez, et al.
Blood Cancer Journal|October 20, 2020
Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortalityJoaquín Martínez-López, María-Victoria Mateos, Cristina Encinas, et al.
Pageof 31

Showing results (291-300 of 308) with videos related to

Sort By:
Pageof 31
Neuron|March 11, 2017
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic OpportunitiesFiona M Menzies, Angeleen Fleming, Andrea Caricasole, et al.
Southern Medical Journal|June 1, 2023
STI Testing among Medicaid Enrollees Initiating PrEP for HIV Prevention in Six Southern StatesPaul Lanier, Susan Kennedy, Angela Snyder, et al.
Vaccines|February 26, 2025
Immunosuppressive Therapy Modifies Anti-Spike IgG Subclasses Distribution After Four Doses of mRNA Vaccination in a Cohort of Kidney Transplant RecipientsIgnacio Juarez, Isabel Pérez-Flores, Arianne S Aiffil Meneses, et al.
Physiological Reports|January 19, 2021
17β-estradiol reduces SARS-CoV-2 infection in vitroRobertha Mariana Rodrigues Lemes, Angelica Jardim Costa, Cynthia Silva Bartolomeo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2025
Palbociclib, trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer: randomised phase II, SOLTI-1303 PATRICIA trialEva Ciruelos, Tomás Pascual, Guillermo Villacampa, et al.
The Journal of Antimicrobial Chemotherapy|September 19, 2023
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimensDaniel Podzamczer, Arkaitz Imaz, Ana Lopez-Lirola, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 28, 2018
Prospective assessment of diagnostic tests for pediatric penicillin allergy: From clinical history to challenge testsMaría Dolores Ibáñez, Pablo Rodríguez Del Río, Eva Maria Lasa, et al.
Plos One|September 8, 2018
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trialsLucia Lopez-Anglada, Cecilia Cueto-Felgueroso, Laura Rosiñol, et al.
Cancers|July 13, 2024
Breast Cancer Patient's Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II-III DiseaseCatalina Falo, Juan Azcarate, Sergi Fernandez-Gonzalez, et al.
Blood Cancer Journal|October 20, 2020
Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortalityJoaquín Martínez-López, María-Victoria Mateos, Cristina Encinas, et al.
Pageof 31